CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial Post author: Post published:April 25, 2024 Post category:News Feed Post comments:0 Comments Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas. You Might Also Like Sickle cell patients who receive Lactated Ringer’s solution for painful episodes experienced significant improvements September 10, 2024 ‘Sleepy cannabis’: Cannabinol increases sleep, study suggests November 13, 2024 Lack of medical oxygen affects millions March 4, 2025 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Sickle cell patients who receive Lactated Ringer’s solution for painful episodes experienced significant improvements September 10, 2024